Company intelligence / Profile preview

Cano Health

Ownership: Public · CANO
Development stage: Commercial

Overview

Cano Health operates as a value-based primary care provider with a focus on senior populations. The company delivers personalized healthcare through its network of medical centers and affiliated providers. It recently emerged from Chapter 11 bankruptcy as a private company after significant restructuring to reduce debt and refocus operations in Florida. No clinical trial results are reported as it does not develop therapeutics.[4][5][7]

Therapeutic areas: OtherInfectious Diseases
Modalities: Not applicable (service-based healthcare provider; not a drug developer)
Industry: Non-Academic Healthcare

Partnerships

Previously sold clinics to Humana subsidiary during restructuring[7]; no major pharma/biotech partnerships reported.

Financials

Market cap: $12.4M
Total revenue: $788.1M
Enterprise value: $1.2B

Beyond the preview

Go deeper on Cano Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cano Health.

Explore the full profile